Comparative Phytochemical Profiling and In-Vitro α-Amylase Inhibitory Activity of Two Botanical Sources of Gojivha: Onosma Bracteatum Wall. and Elephantopus Scaber Linn.

Background: Gojivha is a botanically controversial Ayurvedic drug traditionally indicated in Prameha. Onosma bracteatum Wall. is the source recognised by the Ayurvedic Pharmacopoeia of India (API), whereas Elephantopus scaber Linn. is used as a regional substitute in Maharashtra and South India. Our aim is to test their comparative antidiabetic potential. Objective: To compare the pharmacognostic, phytochemical and in-vitro α-amylase inhibitory profiles of the two sources. Methods: Powdered whole plants were evaluated for organoleptic, microscopic and physicochemical parameters (API methods), preliminary and quantitative phytochemistry (total phenols, tannins, flavonoids), TLC and HPLC (gallic acid, quercetin). Ethanolic extracts (200-1000 μg/mL) were tested for α-amylase inhibition by the DNS method against acarbose, in triplicate. Data were analysed by two-way ANOVA with Tukey's HSD test. Results: O. bracteatum had higher total phenols (21.99% vs 16.92%), tannins (13.54% vs 7.03%), gallic acid (0.74% vs 0.15%) and quercetin (0.33% vs not detected); E. scaber had higher total flavonoids (0.63% vs 0.42%). Inhibition was concentration-dependent for all samples. At 1000 μg/mL, inhibition was 95.04% for acarbose, 74.78% for O. bracteatum and 71.37% for E. scaber. Sample, concentration and their interaction were significant (P < 0.001). Averaged over all concentrations, E. scaber (58.60%) was slightly more active than O. bracteatum (56.31%; mean difference 2.29%, 95% CI 0.45-4.14, P = 0.012), but the ranking reversed at 600 and 1000 μg/mL. Conclusion: Both sources inhibit α-amylase in a dose-dependent manner, with modest and concentration-dependent differences between them, and neither matched acarbose. The findings give preliminary support to E. scaber as a regional alternative source of Gojivha; fractionation, kinetic and in-vivo studies are needed.

Authors

Publication Details

Journal
International Journal of Science and Research (IJSR)
Published
2026-11-04
DOI
https://doi.org/10.21275/sr261031003929
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative Phytochemical Profiling and In-Vitro α-Amylase Inhibitory Activity of Two Botanical Sources of Gojivha: Onosma Bracteatum Wall. and Elephantopus Scaber Linn.

Dipti Kadam, Preethika Rajan
International Journal of Science and Research (IJSR)
Natural Antidiabetic Agents Studies
article

Comparative Phytochemical Profiling and In-Vitro α-Amylase Inhibitory Activity of Two Botanical Sources of Gojivha: Onosma Bracteatum Wall. and Elephantopus Scaber Linn.

Dipti Kadam, Preethika Rajan
article en

Abstract

Background: Gojivha is a botanically controversial Ayurvedic drug traditionally indicated in Prameha. Onosma bracteatum Wall. is the source recognised by the Ayurvedic Pharmacopoeia of India (API), whereas Elephantopus scaber Linn. is used as a regional substitute in Maharashtra and South India. Our aim is to test their comparative antidiabetic potential. Objective: To compare the pharmacognostic, phytochemical and in-vitro α-amylase inhibitory profiles of the two sources. Methods: Powdered whole plants were evaluated for organoleptic, microscopic and physicochemical parameters (API methods), preliminary and quantitative phytochemistry (total phenols, tannins, flavonoids), TLC and HPLC (gallic acid, quercetin). Ethanolic extracts (200-1000 μg/mL) were tested for α-amylase inhibition by the DNS method against acarbose, in triplicate. Data were analysed by two-way ANOVA with Tukey's HSD test. Results: O. bracteatum had higher total phenols (21.99% vs 16.92%), tannins (13.54% vs 7.03%), gallic acid (0.74% vs 0.15%) and quercetin (0.33% vs not detected); E. scaber had higher total flavonoids (0.63% vs 0.42%). Inhibition was concentration-dependent for all samples. At 1000 μg/mL, inhibition was 95.04% for acarbose, 74.78% for O. bracteatum and 71.37% for E. scaber. Sample, concentration and their interaction were significant (P < 0.001). Averaged over all concentrations, E. scaber (58.60%) was slightly more active than O. bracteatum (56.31%; mean difference 2.29%, 95% CI 0.45-4.14, P = 0.012), but the ranking reversed at 600 and 1000 μg/mL. Conclusion: Both sources inhibit α-amylase in a dose-dependent manner, with modest and concentration-dependent differences between them, and neither matched acarbose. The findings give preliminary support to E. scaber as a regional alternative source of Gojivha; fractionation, kinetic and in-vivo studies are needed.

International Journal of Science and Research (IJSR)
Openalex Percentile: Top 12%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Comparative Phytochemical Profiling and In-Vitro α-Amylase Inhibitory Activity of Two Botanical Sources of Gojivha: Onosma Bracteatum Wall. and Elephantopus Scaber Linn. — Dipti Kadam, Preethika Rajan · International Journal of Science and Research (IJSR) (2026) | TGRS Research Map | TGRS